000 01759 a2200493 4500
005 20250514051530.0
264 0 _c20021120
008 200211s 0 0 eng d
022 _a0022-3042
024 7 _a10.1046/j.1471-4159.2002.01148.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCounts, Scott E
245 0 0 _aGalanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons.
_h[electronic resource]
260 _bJournal of neurochemistry
_cOct 2002
300 _a442-51 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBee Venoms
_xpharmacology
650 0 4 _aBucladesine
_xpharmacology
650 0 4 _aCell Count
650 0 4 _aCells, Cultured
650 0 4 _aDopamine
_xmetabolism
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme Induction
_xdrug effects
650 0 4 _aGalanin
_xpharmacology
650 0 4 _aImmunohistochemistry
650 0 4 _aMesencephalon
_xcytology
650 0 4 _aNeurons
_xcytology
650 0 4 _aPertussis Toxin
_xpharmacology
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aRats
650 0 4 _aRats, Inbred F344
650 0 4 _aReceptors, Galanin
650 0 4 _aReceptors, Neuropeptide
_xgenetics
650 0 4 _aTyrosine 3-Monooxygenase
_xmetabolism
650 0 4 _aUp-Regulation
_xdrug effects
700 1 _aMcGuire, Susan O
700 1 _aSortwell, Caryl E
700 1 _aCrawley, Jacqueline N
700 1 _aCollier, Timothy J
700 1 _aMufson, Elliott J
773 0 _tJournal of neurochemistry
_gvol. 83
_gno. 2
_gp. 442-51
856 4 0 _uhttps://doi.org/10.1046/j.1471-4159.2002.01148.x
_zAvailable from publisher's website
999 _c12230708
_d12230708